Compare Procter & Gamble Co (PG) vs uniQure N.V. Ordinary Shares (QURE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Procter & Gamble Co vs uniQure N.V. Ordinary Shares — how do they compare? Procter & Gamble Co trades at $158.81 (market cap $355.46B), while uniQure N.V. Ordinary Shares trades at $20.67 (market cap $1.48B). The key difference: Procter & Gamble Co is far larger — about 240.2× uniQure N.V. Ordinary Shares's market cap, and Procter & Gamble Co pays a 2.85% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Procter & Gamble Co for 132 Days and uniQure N.V. Ordinary Shares for 0 Days on average.
| PG | QURE | |
|---|---|---|
Market Cap | $355.46B | $1.48B |
Volume | 5,731,171 | 2,488,780 |
Sector | Consumer Staples | Health |
52-Week High | $167.18 | $70.59 |
52-Week Low | $138.10 | $9.03 |
Typical Hold Time | 132 Days | 0 Days |
Enterprise Value | $381.30B | $728.62M |
Dividend Yield | 2.85% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Procter & Gamble (PG) trades at $153.05, showing modest daily movement with a slight 0.1% decline. The stock maintains strong technical momentum with bullish moving averages and key support at $152. Fundamentally, PG demonstrates robust profitability with 18.44% net margins and consistent earnings beats, though valuation multiples remain elevated versus peers. Recent corporate developments include dividend declarations and a new WNBA partnership, while analyst sentiment leans positive with a $160.13 consensus target.
PG offers stable dividend income with 69 consecutive years of increases, supported by strong cash flow generation. However, premium valuation and modest revenue growth create near-term headwinds. The stock presents a defensive play amid market volatility, but investors should monitor margin pressures and competitive dynamics in consumer staples. Upside potential exists if the company maintains earnings momentum above expectations.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →
